Ratings by Jefferies (Matthew Stanton)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
10/8/2026 Twist Bioscience TWST New Coverage Hold
(N/A)
166.97
(132.75)
-20.49% Details
9/17/2026 Alpha Teknova Inc. TKNO New Coverage Buy
(N/A)
6.90
(7.08)
2.61% Details
8/5/2026 Azenta, Inc. AZTA Maintain Buy
(N/A)
 
 
  Details
7/28/2026 Repligen RGEN Maintain Hold
(N/A)
 
 
  Details
7/23/2026 BioLife Solutions BLFS Downgrade Hold
(Buy)
31.15
(38.61)
23.95% Details
5/6/2026 Azenta, Inc. AZTA Maintain Buy
(N/A)
 
 
  Details
5/5/2026 Repligen RGEN Maintain Hold
(N/A)
 
 
  Details
2/4/2026 Azenta, Inc. AZTA Maintain Buy
(N/A)
 
 
  Details
11/5/2025 Standard BioTools Inc LAB Maintain Buy
(N/A)
 
 
  Details
10/30/2025 Azenta, Inc. AZTA Upgrade Buy
(Hold)
31.36
(34.09)
8.71% Details
10/28/2025 Repligen RGEN Maintain Hold
(N/A)
 
 
  Details
9/11/2025 Repligen RGEN Maintain Hold
(N/A)
 
 
  Details
8/6/2025 CryoPort CYRX Maintain Hold
(N/A)
 
 
  Details
4/29/2025 Repligen RGEN Maintain Buy
(N/A)
 
 
  Details
3/5/2025 CryoPort CYRX Maintain Hold
(N/A)
 
 
  Details
2/20/2025 Repligen RGEN Maintain Hold
(N/A)
 
 
  Details
2/5/2025 Azenta, Inc. AZTA Maintain Hold
(N/A)
 
 
  Details
8/7/2024 CryoPort CYRX Downgrade Hold
(Buy)
7.79
(16.84)
116.17% Details
5/1/2024 Repligen RGEN Maintain Hold
(N/A)
 
 
  Details
4/4/2024 CryoPort CYRX New Coverage Buy
(N/A)
17.91
(7.79)
-56.5% Details
4/4/2024 Azenta, Inc. AZTA New Coverage Hold
(N/A)
58.82
(31.36)
-46.68% Details
4/4/2024 Standard BioTools Inc LAB New Coverage Buy
(N/A)
2.64
(0.63)
-76.14% Details
4/4/2024 BioLife Solutions BLFS New Coverage Buy
(N/A)
17.60
(38.61)
119.38% Details